BiomEdit Secures $18.4M Series B Funding Led By Anterra Capital With Multiple Investors

BiomEdit, an animal health biotechnology company based in Greenfield, Indiana, raised $18.4M in Series B funding led by Anterra Capital, with backing from Nutreco, AgriZeroNZ, Elevate Ventures, and Betagro Ventures. Founded and led by CEO Aaron Schacht, the company focuses on microbiome and synthetic biology to develop next-gen solutions for livestock and pet health. The new capital will support expanded operations, R&D, and regulatory progress, including USDA approvals for its lead product BE-101. INVESTORS: Anterra Capital, Nutreco, AgriZeroNZ, Elevate Ventures & Betagro Ventures ROUND: Series B AMOUNT: $18,400,000 HQ: #Greenfield #Indiana #VentureCapital #BiomEdit #AaronSchacht #AnterraCapital #Nutreco #AgriZeroNZ #ElevateVentures #BetagroVentures #TradedVC